Efficacy and Safety of Ivarmacitinib, a Selective JAK1 Inhibitor, in Patients With Active Ankylosing Spondylitis: Results From an Adaptive Seamless Phase 2/3 Trial

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Xu Liu, Liling Xu, Cheng Zhao, Shengyun Liu, Lingyun Sun, Lei Yang, Xiaoyan Xu, Rui Wu, Xiumei Liu, Jing Zhang, Shengqian Xu, Ping Zhu, Haiying Chen, Xiaoxia Wang, Changsong Lin, Jin Lin, Feng Zhan, Hua Wei, Qingchun Huang, Huaxiang Liu, Xinmei Ma, Guixiu Shi, Yuewu Lu, Xiuqin Geng, Zhenyu Jiang, Ning Zhang, Kaijiang Tang, Ronghua Zhang, Yi Zhao, Luan Xue, Shulin Song, Xiaofei Shi, Zhiyi Zhang, Pan Liu, Hui Wang, Zhanguo Li
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Arthritis & Rheumatology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet